Ortiz-Espinosa Sergio, Morales Xabier, Senent Yaiza, Alignani Diego, Tavira Beatriz, Macaya Irati, Ruiz Borja, Moreno Haritz, Remírez Ana, Sainz Cristina, Rodriguez-Pena Alejandro, Oyarbide Alvaro, Ariz Mikel, Andueza Maria P, Valencia Karmele, Teijeira Alvaro, Hoehlig Kai, Vater Axel, Rolfe Barbara, Woodruff Trent M, Lopez-Picazo Jose Maria, Vicent Silvestre, Kochan Grazyna, Escors David, Gil-Bazo Ignacio, Perez-Gracia Jose Luis, Montuenga Luis M, Lambris John D, Ortiz de Solorzano Carlos, Lecanda Fernando, Ajona Daniel, Pio Ruben
Program in Solid Tumors, Cima-University of Navarra, Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain; Navarra's Health Research Institute (IDISNA), Pamplona, Spain.
Program in Solid Tumors, Cima-University of Navarra, Pamplona, Spain; Navarra's Health Research Institute (IDISNA), Pamplona, Spain; Imaging Platform, CIMA, Pamplona, Spain.
Cancer Lett. 2022 Mar 31;529:70-84. doi: 10.1016/j.canlet.2021.12.027. Epub 2021 Dec 28.
Myeloid-derived suppressor cells (MDSCs) play a major role in cancer progression. In this study, we investigated the mechanisms by which complement C5a increases the capacity of polymorphonuclear MDSCs (PMN-MDSCs) to promote tumor growth and metastatic spread. Stimulation of PMN-MDSCs with C5a favored the invasion of cancer cells via a process dependent on the formation of neutrophil extracellular traps (NETs). NETosis was dependent on the production of high mobility group box 1 (HMGB1) by cancer cells. Moreover, C5a induced the surface expression of the HMGB1 receptors TLR4 and RAGE in PMN-MDSCs. In a mouse lung metastasis model, inhibition of C5a, C5a receptor-1 (C5aR1) or NETosis reduced the number of circulating-tumor cells (CTCs) and the metastatic burden. In support of the translational relevance of these findings, C5a was able to stimulate migration and NETosis in PMN-MDSCs obtained from lung cancer patients. Furthermore, myeloperoxidase (MPO)-DNA complexes, as markers of NETosis, were elevated in lung cancer patients and significantly correlated with C5a levels. In conclusion, C5a induces the formation of NETs from PMN-MDSCs in the presence of cancer cells, which may facilitate cancer cell dissemination and metastasis.
髓系来源的抑制细胞(MDSCs)在癌症进展中起主要作用。在本研究中,我们探究了补体C5a增强多形核MDSCs(PMN-MDSCs)促进肿瘤生长和转移扩散能力的机制。用C5a刺激PMN-MDSCs有利于癌细胞通过依赖中性粒细胞胞外陷阱(NETs)形成的过程进行侵袭。NETosis依赖于癌细胞产生的高迁移率族蛋白B1(HMGB1)。此外,C5a诱导PMN-MDSCs中HMGB1受体TLR4和RAGE的表面表达。在小鼠肺转移模型中,抑制C5a、C5a受体1(C5aR1)或NETosis可减少循环肿瘤细胞(CTC)的数量和转移负担。为支持这些发现的转化相关性,C5a能够刺激从肺癌患者获得的PMN-MDSCs的迁移和NETosis。此外,作为NETosis标志物的髓过氧化物酶(MPO)-DNA复合物在肺癌患者中升高,且与C5a水平显著相关。总之,在癌细胞存在的情况下,C5a诱导PMN-MDSCs形成NETs,这可能促进癌细胞的播散和转移。
Front Immunol. 2019-2-7
Med Oncol. 2025-8-27
Clin Transl Med. 2025-6
Front Immunol. 2025-5-29
J Proteome Res. 2025-5-2
Zhongguo Fei Ai Za Zhi. 2025-1-20